🇺🇸 FDA
Patent

US 12414942

Compositions, methods, and systems for treating presbyopia

granted A61KA61K31/439A61K31/498

Quick answer

US patent 12414942 (Compositions, methods, and systems for treating presbyopia) held by LENZ THERAPEUTICS OPERATIONS, INC. expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LENZ THERAPEUTICS OPERATIONS, INC.
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/439, A61K31/498, A61K9/0048, A61P